Results 111 to 120 of about 734,253 (148)

Advances in lenvatinib monotherapy and combination therapies in anaplastic thyroid cancer (Review). [PDF]

Oncol Lett
Xu L, Zhang W, Wang Y, Le Q, Xie Y, Yu K, Wu X.   +6 more
europepmc   +1 more source

Breaking Cancer's Momentum: CDK4/6 Inhibitors and the Promise of Combination Therapy. [PDF]

Cancers (Basel)
Liu Y, Park S, Li Y.
europepmc   +1 more source

Assessing Auranofin for Second-Line Use in Chemoresistant Ovarian Cancer: Effects on Tumour Spheroid and Primary Cell Growth. [PDF]

J Cell Mol Med
Rosamaria M, Matteo B, Tania G, Tania F, Modesti A, Caterina P, Flavia S, Massimiliano F, Francesca M.   +8 more
europepmc   +1 more source

In Vivo PK-PD and Drug-Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia. [PDF]

Pharmaceuticals (Basel)
Jin G, Zheng K, Liu S, Yi H, Wei W, Xu C, Xiang X, Kang Y.   +7 more
europepmc   +1 more source

Mortality Risk Analysis of Combination Antiplatelet Therapy in Patients with Ischemic Stroke and Acute Kidney Injury: A Retrospective Cohort Analysis of the MIMIC-IV Database. [PDF]

Diseases
Zhou Q, Xu H, Long S, Wei W, Li X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Combination Drug Therapy

Journal of the American Medical Directors Association, 2005
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Barbara J. Zarowitz, Eric G. Tangalos
openaire   +3 more sources

Combination drug therapy for dyslipidemia

Current Atherosclerosis Reports, 1999
Effective treatment of dyslipidemia improves prognosis. Statin therapy has been documented to decrease the cardiovascular event rate in the setting of elevated low-density lipoprotein (LDL) cholesterol levels and coronary heart disease, but most patients are not treated to the target (LDL
Khaldoon Alaswad, James H. O'Keefe, Richard M. Moe   +2 more
openaire   +3 more sources

Combination Drug Therapy in Psychopharmacology

The Journal of Clinical Pharmacology, 1975
The frequency with which a psychotropic agent is used in combination with another drug preparation is emphasized. The authors present an update of the clinical and theoretical knowledge bearing on combination drug therapy in psychopharmacology. Drug combination interactions that enhance clinical efficacy and those that either diminish it or even ...
Bonnie J. Pray, William E. Thornton
openaire   +3 more sources

Combination Drug Therapy for Familial Combined Hyperlipidemia

Annals of Internal Medicine, 1988
To compare the efficacy of gemfibrozil and colestipol with gemfibrozil and lovastatin in patients with familial combined hyperlipidemia.A prospective, randomized trial.An outpatient clinical research center in a tertiary care center.Seventeen patients with familial combined hyperlipidemia documented by studies of first-degree relatives; nine patients ...
Cara East, Scott M. Grundy, David W. Bilheimer   +2 more
openaire   +3 more sources

Combination drug–diet therapies for dyslipidemia

Translational Research, 2010
Expense, high drug dose, and low compliance to strict dietary therapies are current issues surrounding modern drug- and diet-based lipid-lowering approaches. Furthermore, variable patient outcomes and suboptimal response to both drug and diet therapies are increasingly evident. Therefore, the question arises as to whether more emphasis should be placed
Rideout, Todd C, Harding, Scott V, Marinangeli, Christopher P F, Jones, Peter J H   +3 more
openaire   +4 more sources